A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient

Research output: Contribution to journalArticlepeer-review

Abstract

This study is written to report a case of 67-year-old female with known autoimmune hepatitis (AIH) who developed balance and walking difficulties. Clinical and imaging investigations were more suggestive of AIH suffering from lymphoproliferative disease. To identify the underlying suspected lym-phoproliferative disease, series of brain scans were performed, which showed multiple brain lesions. This is a report on a striking case of multiple contrast enhanced brain lesions discovered in an AIH patient that was resolved upon withdrawal of azathioprine. Many side effects of azathioprine are acknowledged around the world; however, to the very best of our knowledge, an article on azathioprine inducing suspected malignancy was never reported.

Original languageEnglish
Pages (from-to)78-81
Number of pages4
JournalHepatology Forum
Volume4
Issue number2
DOIs
Publication statusPublished - May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Autoimmune hepatitis
  • azathioprine therapy
  • immunosuppressive drugs
  • reversible neural lesions

Fingerprint

Dive into the research topics of 'A case report of reversible intracranial lesions after long-term Azathioprine therapy in an autoimmune hepatitis patient'. Together they form a unique fingerprint.

Cite this